Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia

29.06.2023 - Cosmo Pharmaceuticals N.V. / Key word(s): Study Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia 29.06.2023 / 06:15 GMT/BST Dublin, Ireland – June 29, 2023: Cosmo Pharmaceuticals N.V. (SIX: ... Seite 1

Related Keywords

Poland ,Germany ,Georgia ,United States ,Clascoterone Cortexolone , ,Target Area Hair Count ,Patient Reported Outcome ,Cosmo Pharmaceuticals ,